Traditional cancer treatments have followed a “one size fits all” approach, which limits efficacy and often results in significant side effects. This research project aims to develop an approach to predict the impact of cancer missense mutations on the drug-protein interactions of cancer treatments. The approach will use the patient’s own genomic profile and will […]
Read More